October 13, 2016

An interview with Dr. David LeBrun, leader of OICR’s new molecular pathology network

Dr. David LeBrun

Dr. David LeBrun is heading up the Ontario Molecular Pathology Research Network (OMPRN), which was announced at the end of September. It will be funded by OICR, based at Queen’s University and will include pathologists from across the province.

Continue reading – An interview with Dr. David LeBrun, leader of OICR’s new molecular pathology network

September 29, 2016

OICR funding new network to enhance molecular pathology research in Ontario

omprn-announce

Today OICR announced the launch of the Ontario Molecular Pathology Research Network (OMPRN), which will be based at Queen’s University and will bring together pathologists across the province.

Pathology is key to the early detection, diagnosis and treatment of cancer. An accurate diagnosis can provide better prognostic information and allow doctors to better target therapies. Pathology research can also lead to the development of new treatments that target specific cancer-driving mutations, genes and pathways, reducing the need for treatments with unwanted side effects.

Continue reading – OICR funding new network to enhance molecular pathology research in Ontario